Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ultralife (ULBI) EBIT (2016 - 2025)

Historic EBIT for Ultralife (ULBI) over the last 15 years, with Q3 2025 value amounting to -$951000.0.

  • Ultralife's EBIT fell 28610.57% to -$951000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $6.2 million, marking a year-over-year decrease of 4911.04%. This contributed to the annual value of $10.0 million for FY2024, which is 517.15% up from last year.
  • As of Q3 2025, Ultralife's EBIT stood at -$951000.0, which was down 28610.57% from $2.3 million recorded in Q2 2025.
  • In the past 5 years, Ultralife's EBIT registered a high of $4.1 million during Q1 2024, and its lowest value of -$951000.0 during Q3 2025.
  • In the last 4 years, Ultralife's EBIT had a median value of $2.1 million in 2023 and averaged $2.0 million.
  • As far as peak fluctuations go, Ultralife's EBIT skyrocketed by 1552692.31% in 2024, and later plummeted by 28610.57% in 2025.
  • Ultralife's EBIT (Quarter) stood at $1.1 million in 2021, then skyrocketed by 234.46% to $3.6 million in 2023, then crashed by 59.61% to $1.5 million in 2024, then crashed by 164.52% to -$951000.0 in 2025.
  • Its last three reported values are -$951000.0 in Q3 2025, $2.3 million for Q2 2025, and $3.4 million during Q1 2025.